Regitrat
Treatment of PH+ chronic or advanced myelogenous leukemia (CML).
Therapeutic Area
Antineoplastic + Onco-Hematology + Protein Kinase Inhibitor
Active Ingredient
Bosutinib
Line
Hematology + Oncology
Dosage Forms
100 mg x 28 coated tablets
400 mg x 28 coated tablets
500 mg x 28 coated tablets
